相关实验视频

Updated: Jun 21, 2025

Predictive Immune Modeling of Solid Tumors

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

免疫机制和预测生物标志物与III阶段黑色素瘤中新辅助免疫疗法反应相关

Amanda Braga Figueiredo^1,2,3, Milton José Barros E Silva⁴, Guilherme Ferreira de Britto Evangelista¹

¹Translational Immuno-Oncology Group, International Research Center, A.C. Camargo Cancer Center, São Paulo, SP, Brazil.

|July 8, 2024

概括

新辅助免疫检查点封锁对晚期黑色素瘤有前途,但并非所有患者都能反应. 研究人员确定了像CTACK,CXCL9,CD95,PD-1,CD161和PD-L2这样的免疫标志物,可以预测治疗的成功或失败.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
皮肤病学皮肤病学

背景情况:

第三阶段黑色素瘤治疗得到了改善,但复发仍然很常见.
新辅助免疫检查点封锁提供了早期治疗和增强的免疫反应.
需要预测标记来识别不响应者并优化治疗.

研究的目的:

评估接受新辅助免疫检查点抑制剂的晚期黑色素瘤患者的全身和瘤免疫特征.
识别可预测对新辅助免疫疗法的反应的免疫标志物.
了解治疗失败背后的免疫机制.

主要方法:

在一组晚期黑色素瘤患者中分析全身和瘤免疫特征.
在治疗前评估化学激素水平 (CTACK,CXCL9).
在CD8+ T淋巴细胞上评估免疫细胞标记物 (CD95,PD-1,CD161,PD-L2).

主要成果:

治疗前CTACK和CXCL9水平升高与治疗反应相关.
较高的CD95表达在CD8+T细胞上表明了良好的预后.
增加PD-1,CD161和PD-L2表达与较差的结果有关.

结论:

在黑色素瘤中,CTACK和CXCL9显示出作为新辅助免疫疗法的预测生物标志物的潜力.
CD95,PD-1,CD161和PD-L2表达水平可以为预后评估提供信息.
这些发现有助于理解免疫反应,并制定针对晚期黑色素瘤的个性化治疗策略.

关键词:

生物标志物生物标志物免疫调节是一种免疫调节.免疫治疗是一种免疫疗法.黑色素瘤是一种黑色素瘤.新辅助疗法是一种新辅助疗法.

更多相关视频

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...